METASTATIC LUNG CANCER
Clinical trials for METASTATIC LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets Hard-to-Treat lung cancer mutation
Disease control OngoingThis phase 2 trial tests whether combining the targeted drug adagrasib with immunotherapy (pembrolizumab) and chemotherapy can shrink tumors or delay progression in people with advanced non-small cell lung cancer that has a specific KRAS G12C mutation. The study enrolls adults wh…
Matched conditions: METASTATIC LUNG CANCER
Phase: PHASE2 • Sponsor: Mirati Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New antibody drug takes on advanced tumors in first human trial
Disease control OngoingThis early-phase trial tests an experimental drug called IPH5301, which targets a protein called CD73 on cancer cells. The study involves 27 people with advanced solid tumors, including breast, lung, and pancreatic cancers. In the first part, IPH5301 is given alone to find a safe…
Matched conditions: METASTATIC LUNG CANCER
Phase: PHASE1 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill targets tough cancers: early trial underway
Disease control OngoingThis study tests an experimental oral drug called silevertinib (BDTX-1535) in about 200 adults with advanced non-small cell lung cancer or glioblastoma, a type of brain cancer. The drug is designed to block specific EGFR mutations that help these cancers grow. The trial has two p…
Matched conditions: METASTATIC LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Targeted radiation may extend life for patients with limited bone metastases
Disease control OngoingThis study looks at whether adding a high-precision type of radiation called SBRT to usual cancer treatments (like hormone therapy or chemo) can delay cancer growth in people with breast, lung, or prostate cancer that has spread to 1 to 5 bones. About 168 adults aged 18-75 with g…
Matched conditions: METASTATIC LUNG CANCER
Phase: NA • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug shows promise for tough lung cancers
Disease control OngoingThis study tests a new drug called DS-1062a in 100 people with advanced non-small cell lung cancer that has worsened after standard treatments. The drug is given every three weeks and aims to shrink tumors. Researchers will also study how the drug affects the immune system and lo…
Matched conditions: METASTATIC LUNG CANCER
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Talking it out: team approach may ease tough cancer decisions
Symptom relief OngoingThis study tests whether an extra meeting with a team of doctors, a palliative care specialist, and a psychologist can help patients with advanced cancer feel less torn about their next treatment. 62 adults with metastatic lung, breast, colon, ovarian, or prostate cancer who need…
Matched conditions: METASTATIC LUNG CANCER
Phase: NA • Sponsor: Hospital Universitario San Ignacio • Aim: Symptom relief
Last updated Jun 26, 2026 16:52 UTC